News Focus
News Focus
Followers 63
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: bladerunner1717 post# 2634

Monday, 02/23/2009 7:38:36 PM

Monday, February 23, 2009 7:38:36 PM

Post# of 3757
"Why has Tyzeka been such a dog? I thought you once said it would be a rival for Baraclude."

I will help, seeing as Dew ignored your question. I also think it is instructive, as safety counts for so much when there is competition in the therapy space, and IDIX has an atrocious record of concealing safety issues (e.g. HCV candidate too)

It is indeed true concerning the past Barraclude comparisons –

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=16357377

- and there was disbelief even when IDIX issued cautious forecasts -

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=16670487


Hidden from the read-me-first, suppressed for years on iHub in general, here is the central issue - they claimed the lower price was a "marketing tactic" - this is where I questioned that there must be something wrong -

http://investorshub.advfn.com/boards/read_msg.asp?message_id=21343675

- soon there was a relevation on the board, like no-one knew before, that there WAS a big problem:

http://investorshub.advfn.com/boards/read_msg.asp?message_id=21392641


So, I wouldnt touch IDIX with a 10-foot pole - but I do like SPPI these days......very interesting.....

"....on the biotech battle-field, you need some élan...."